Cd20-negative diffuse large b-cell lymphoma subtype: a look at texas cancer registry
Introduction CD20-negative diffuse large B-cell lymphoma (DLBCL) histologic subtypes are rare and aggressive lymphomas. As these lymphomas are rare, most epidemiology and survival information is derived from case reports and case series. The main objective of this research was to estimate CD20-negat...
Main Authors: | Kartik Anand, Allyne M. Ensor, Joe E. Ensor |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Hematology Reports |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8930 |
Similar Items
-
Diffuse Large B-cell Lymphoma of the Uterus: A Propensity Score Matched Analysis of the Texas Cancer Registry
by: A. Ensor, et al.
Published: (2020-09-01) -
Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report
by: Shuai Luo, et al.
Published: (2022-12-01) -
Genomic profiling of CD20 negative diffuse large B cell lymphoma identifies targetable mutations: A case report
by: M. Gohar Maqbool, et al.
Published: (2020-11-01) -
Primary Nodal Unclassifiable CD20 Negative Diffuse Large B-cell Lymphoma With Dual and Gene Rearrangement: A Diagnostic Challenge
by: Ita Hadžisejdić, et al.
Published: (2023-01-01) -
Renal Involvement of CD20-Negative Intravascular Large B Cell Lymphoma with Neurological Manifestations
by: Faten Aqeel, et al.
Published: (2022-01-01)